| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |